Landscape Capital Management, L.L.C. Incyte Corp Transaction History

Landscape Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $1.2 Million - $1.42 Million	-16,440 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $340,935 - $472,943	-5,364 Reduced 24.6%	16,440 $1.41 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $84,825 - $101,413	1,450 Added 7.12%	21,804 $1.39 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $1.26 Million - $1.51 Million	20,354 New	20,354 $1.41 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.